Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 79 Bevacizumab 66 Drug Therapy 65 Cisplatin 64 Carboplatin 63 Magnetic Resonance Spectroscopy 61 Radiotherapy 57 Cyclophosphamide 55 Gemcitabine 54 pembrolizumab 53 Oxaliplatin 50 Capecitabine 50 toripalimab 42 Paclitaxel 41 tislelizumab 40 Standard of Care 40 Biopsy 37 fludarabine 36 Fluorouracil 35 venetoclax 33 Injections 33 Blood Specimen Collection 31 Immune Checkpoint Inhibitors 30 anlotinib 29 Nivolumab 29 Surgical Procedures, Operative 28 Irinotecan 27 Docetaxel 27 Dexamethasone 27 Leucovorin 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Dipeptidyl-Peptidase IV Inhibitors × 1 year × Clear all

NCT07436663 2026-02-27

SGLT2i/DPPi

Tanta University

Phase 4 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡